March 6, 2024 Comments Off on New patent for Adamas Operations drug OSMOLEX ER Posted in: Patent Added Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Adamas Operations and is included in one NDA. It is available from one supplier. There are eighteen…
The post New patent for Adamas Operations drug OSMOLEX ER appeared first…
March 6, 2024 Comments Off on New patent expiration for Evofem Inc drug PHEXXI Posted in: Uncategorized
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Evofem Inc drug PHEXXI appeared first on DrugPat…
